ANIX
Anixa Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$93.54M
P/E Ratio
—
EPS
$-0.32
Beta
0.65
52W High
$5.46
52W Low
$2.44
50-Day MA
$2.83
200-Day MA
$3.34
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Anixa Biosciences Inc
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is headquartered in San Jose, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-13.10M |
| Operating Margin | 0.00% |
| Return on Equity | -68.10% |
| Return on Assets | -40.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.45 |
| Price-to-Book | 6.20 |
| Price-to-Sales (TTM) | 377.78 |
| EV/Revenue | 274.8 |
| EV/EBITDA | -8.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $33.53M |
| Float | $31.72M |
| % Insiders | 5.38% |
| % Institutions | 15.41% |
Historical Volatility
HV 10-Day
31.35%
HV 20-Day
41.45%
HV 30-Day
51.19%
HV 60-Day
48.44%
HV Rank
34.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($11.00 target)
1
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026